Company profile for Purdue Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Canadians are enjoying better healthcare as a result of the contributions of Purdue Pharma Canada. As one of the leading pharmaceutical companies in Canada, we further research in the field of drug delivery and market products for the treatment of pain, attention deficit hyperactivity disorder (ADHD), gastrointestinal disorders, respiratory disease, infection control and urinary incontinence.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
Purdue Pharma Canada, 575 Granite Court, Pickering, ON Canada L1W 3W8
Telephone
Telephone
1. 905-420-64002. 1-800-387-5349
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercepharma.com/pharma/sackler-family-purdue-pharma-can-settle-opioid-claims-74b-deal-judge-signs-bankruptcy

FIERCE PHARMA
18 Nov 2025

https://www.businesswire.com/news/home/20251114084437/en/Bankruptcy-Court-to-Confirm-Purdue-Pharmas-Plan-of-Reorganization

BUSINESSWIRE
14 Nov 2025

https://www.reuters.com/legal/government/purdue-pharma-gets-over-99-voting-support-bankruptcy-plan-2025-10-21/

REUTERS
23 Oct 2025

https://www.pharmiweb.com/press-release/2025-10-21/purdue-pharma-lp-plan-of-reorganization-receives-overwhelming-creditor-support

PHARMIWEB
21 Oct 2025

https://www.businesswire.com/news/home/20250917676784/en/Investigational-Drug-Tinostamustine-to-be-Included-in-GBM-AGILE-Clinical-Trial-for-Glioblastoma

BUSINESSWIRE
17 Sep 2025

https://www.businesswire.com/news/home/20250908639413/en/Results-From-Sunobinop-Phase-1B-Study-in-Patients-With-Interstitial-CystitisBladder-Pain-Syndrome-Announced

BUSINESSWIRE
09 Sep 2025

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty